Cargando…

Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019

Detalles Bibliográficos
Autores principales:	Doyle, Joshua D., Chung, Jessie R., Kim, Sara S., Gaglani, Manjusha, Raiyani, Chandni, Zimmerman, Richard K., Nowalk, Mary Patricia, Jackson, Michael L., Jackson, Lisa A., Monto, Arnold S., Martin, Emily T., Belongia, Edward A., McLean, Huong Q., Foust, Angie, Sessions, Wendy, Berman, LaShondra, Garten, Rebecca J., Barnes, John R., Wentworth, David E., Fry, Alicia M., Patel, Manish M., Flannery, Brendan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2019
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375657/ https://www.ncbi.nlm.nih.gov/pubmed/30763298 http://dx.doi.org/10.15585/mmwr.mm6806a2

Ejemplares similares

Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 2014
por: Flannery, Brendan, et al.
Publicado: (2014)

Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018
por: Flannery, Brendan, et al.
Publicado: (2018)

Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017
por: Flannery, Brendan, et al.
Publicado: (2017)

Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015
por: Flannery, Brendan, et al.
Publicado: (2015)

Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
por: Dawood, Fatimah S., et al.
Publicado: (2020)

535 Effectiveness of Seasonal Influenza Vaccines against Influenza A(H1N1)pdm09 Illness during Three Influenza Seasons, US Flu VE Network
por: Flannery, Brendan, et al.
Publicado: (2014)

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017
por: Gaglani, Manjusha, et al.
Publicado: (2020)

650 Relative Vaccine Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2–18 Years in Two Seasons – US Flu VE Network
por: Clippard, Jessie, et al.
Publicado: (2014)

Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season
por: Flannery, Brendan, et al.
Publicado: (2017)

Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022
por: Chung, Jessie R., et al.
Publicado: (2022)

Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness — United States, February 2013
por: Jackson, Lisa, et al.
Publicado: (2013)

2734. Lack of Influence of Early Exposure to Influenza A(H3N2) Viruses on Vaccine Effectiveness Against A(H3N2)-Associated Illness in US Children <18 Years, 2016–2018
por: Ladva, Chandresh N, et al.
Publicado: (2019)

Vaccine effectiveness against COVID‐19 among symptomatic persons aged ≥12 years with reported contact with COVID‐19 cases, February–September 2021
por: Chung, Jessie R., et al.
Publicado: (2022)

2760. Accounting for Vaccination History in Estimates of Current Season Vaccine Effectiveness in the US Flu VE Network, 2012–2013 Through 2017–2018
por: Kim, Sara S, et al.
Publicado: (2019)

Hospitalization following outpatient medical care for influenza: US influenza vaccine effectiveness network, 2011‐12—2015‐16
por: Appiah, Grace D., et al.
Publicado: (2018)

Influenza Vaccine Effectiveness among Elderly and Non-Elderly Adults Aged ≥45 Years in the United States, 2011–2012 to 2015–2016
por: Havers, Fiona P, et al.
Publicado: (2017)

Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons
por: Havers, Fiona P., et al.
Publicado: (2018)

988. Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010–2018
por: Flannery, Brendan L, et al.
Publicado: (2018)

Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2
por: Chung, Jessie R, et al.
Publicado: (2020)

Classification and Regression Tree (CART) analysis to predict influenza in primary care patients
por: Zimmerman, Richard K., et al.
Publicado: (2016)

900. Effect of Influenza Vaccine Priming on Current Season Vaccine Effectiveness among Children and Adolescents, US Flu VE Network 2014–2015 Through 2017–2018
por: Chung, Jessie R, et al.
Publicado: (2019)

Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011‐2016
por: Balasubramani, Goundappa K., et al.
Publicado: (2020)

Relationship between Telework Experience and Presenteeism during COVID-19 Pandemic, United States, March–November 2020
por: Shafer, Livvy, et al.
Publicado: (2023)

1789. Comparison of influenza vaccine effectiveness estimates from the US Influenza Vaccine Effectiveness Network and Electronic Health Record Source Population Data, 2021-2022
por: McLean, Callie, et al.
Publicado: (2023)

Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study
por: Jackson, Michael L., et al.
Publicado: (2021)

2062. Improving Antibiotic Prescribing in the Ambulatory Care Setting—Stewardship through Influenza Vaccination, US Flu VE Network 2013–2014 Through 2017–2018
por: Smith, Emily, et al.
Publicado: (2019)

Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type
por: McLean, Huong Q., et al.
Publicado: (2015)

Interim Estimates of 2022–23 Seasonal Influenza Vaccine Effectiveness — Wisconsin, October 2022–February 2023
por: McLean, Huong Q., et al.
Publicado: (2023)

Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022
por: Kim, Sara S., et al.
Publicado: (2022)

Paid Leave and Access to Telework as Work Attendance Determinants during Acute Respiratory Illness, United States, 2017–2018
por: Ahmed, Faruque, et al.
Publicado: (2020)

1161. Effectiveness of the Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Infections in Outpatient Immunocompromised Adults, 2017-2018
por: Kramer, Kailey Hughes, et al.
Publicado: (2023)

Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018–2022
por: Ahmed, Faruque, et al.
Publicado: (2023)

Human Infections with Novel Reassortant Influenza A(H3N2)v Viruses, United States, 2011
por: Lindstrom, Stephen, et al.
Publicado: (2012)

Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network
por: Tartof, Sara Y., et al.
Publicado: (2023)

Update: Influenza Activity — United States, October 2, 2016–February 4, 2017
por: Blanton, Lenee, et al.
Publicado: (2017)

Update: Influenza Activity — United States, October 1, 2017–February 3, 2018
por: Budd, Alicia P., et al.
Publicado: (2018)

Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory Illness
por: Flannery, Brendan, et al.
Publicado: (2020)

Update: Influenza Activity — United States, September 30, 2018–February 2, 2019
por: Blanton, Lenee, et al.
Publicado: (2019)

995. Effectiveness of Influenza Vaccine for Prevention of Influenza-Associated Hospitalizations Among High-Risk Adults in the United States, 2015–2016
por: Alyanak, Elif, et al.
Publicado: (2018)

Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 U.S. Communities
por: Griffin, Marie R., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_94d7qshk6ce4t6qtdj1p5p2ifq